Literature DB >> 33833398

CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma.

Pavan Kumar Kakumani1,2, Tanit Guitart3, Francois Houle4,5, Louis-Mathieu Harvey4,5, Benjamin Goyer6,7, Lucie Germain6,7, Fátima Gebauer3,8, Martin J Simard9,10.   

Abstract

MicroRNAs and RNA-binding proteins (RBPs) primarily target the 3' UTR of mRNAs to control their translation and stability. However, their co-regulatory effects on specific mRNAs in physiology and disease are yet to be fully explored. CSDE1 is an RBP that promotes metastasis in melanoma and mechanisms underlying its oncogenic activities need to be completely defined. Here we report that CSDE1 interacts with specific miRNA-induced silencing complexes (miRISC) in melanoma. We find an association of CSDE1 with AGO2, the essential component of miRISC, which is facilitated by target mRNAs and depends on the first cold shock domain of CSDE1. Both CSDE1 and AGO2 bind to 3' UTR of PMEPA1. CSDE1 counters AGO2 binding, leading to an increase of PMEPA1 expression. We also identify a miRNA, miR-129-5p, that represses PMEPA1 expression in melanoma. Collectively, our results show that PMEPA1 promotes tumorigenic traits and that CSDE1 along with miR-129-5p/AGO2 miRISC act antagonistically to fine-tune PMEPA1 expression toward the progression of melanoma.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33833398     DOI: 10.1038/s41388-021-01767-9

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

Review 1.  A guide to microRNA-mediated gene silencing.

Authors:  Miguel Quévillon Huberdeau; Martin J Simard
Journal:  FEBS J       Date:  2018-10-08       Impact factor: 5.542

2.  Global analyses of the effect of different cellular contexts on microRNA targeting.

Authors:  Jin-Wu Nam; Olivia S Rissland; David Koppstein; Cei Abreu-Goodger; Calvin H Jan; Vikram Agarwal; Muhammed A Yildirim; Antony Rodriguez; David P Bartel
Journal:  Mol Cell       Date:  2014-03-13       Impact factor: 17.970

3.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

Review 4.  Melanoma.

Authors:  Dirk Schadendorf; David E Fisher; Claus Garbe; Jeffrey E Gershenwald; Jean-Jacques Grob; Allan Halpern; Meenhard Herlyn; Michael A Marchetti; Grant McArthur; Antoni Ribas; Alexander Roesch; Axel Hauschild
Journal:  Nat Rev Dis Primers       Date:  2015-04-23       Impact factor: 52.329

Review 5.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

6.  Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.

Authors:  Y Xu; T Brenn; E R S Brown; V Doherty; D W Melton
Journal:  Br J Cancer       Date:  2012-01-05       Impact factor: 7.640

Review 7.  The role of MicroRNAs in human cancer.

Authors:  Yong Peng; Carlo M Croce
Journal:  Signal Transduct Target Ther       Date:  2016-01-28

8.  Differences in microRNA expression between melanoma and healthy adjacent skin.

Authors:  Mariya Aksenenko; Nadezhda Palkina; Anna Komina; Liubov Tashireva; Tatiana Ruksha
Journal:  BMC Dermatol       Date:  2019-01-05

Review 9.  Regulation of microRNA function in animals.

Authors:  Luca F R Gebert; Ian J MacRae
Journal:  Nat Rev Mol Cell Biol       Date:  2019-01       Impact factor: 94.444

10.  Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma.

Authors:  Luigi Fattore; Ciro Francesco Ruggiero; Maria Elena Pisanu; Domenico Liguoro; Andrea Cerri; Susan Costantini; Francesca Capone; Mario Acunzo; Giulia Romano; Giovanni Nigita; Domenico Mallardo; Concetta Ragone; Maria Vincenza Carriero; Alfredo Budillon; Gerardo Botti; Paolo Antonio Ascierto; Rita Mancini; Gennaro Ciliberto
Journal:  Cell Death Differ       Date:  2018-09-25       Impact factor: 15.828

View more
  3 in total

Review 1.  Modulation of miRISC-Mediated Gene Silencing in Eukaryotes.

Authors:  Courtney F Jungers; Sergej Djuranovic
Journal:  Front Mol Biosci       Date:  2022-02-14

Review 2.  AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer.

Authors:  Pavan Kumar Kakumani
Journal:  Transl Oncol       Date:  2022-04-26       Impact factor: 4.803

3.  m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.

Authors:  Cheng Zhang; JinHui Liu; Hongyu Guo; Dandan Hong; Jing Ji; Qin Zhang; Qun Guan; Qingling Ren
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.